There is one clear winner on Wall Street on the Walgreens-Rite Aid mega deal
Thomson Reuters
Swiss bank UBS is the sole advisor to the buyer, Walgreen, and is the sole provider of bridge financing for the deal.
That should generate a monster payday, totaling up to $65 million according to Jeffery Nassof, with M&A consulting firm Freeman & Co.
He told Business Insider that advisory fees should come in at around $25 million. The bridge financing for the deal could net the bank another $25 million to $40 million, he said.
Rite Aid shares soared more than 40% on Tuesday after The Wall Street Journal reported that a deal was close. The companies will host a conference call on Wednesday morning to discuss the transaction.
The deal marks a big win for UBS, which ranked 11 for US M&A prior to the deal's announcement, with about 11% of market share.
The deal is also a win for Citigroup, which is advising Rite Aid on the transaction. It has become a relative rarity to have just one adviser on either side on such big deals.
The bank was not immediately available for comment.
- Global stocks rally even as Sensex, Nifty fall sharply on Friday
- In second consecutive week of decline, forex kitty drops $2.28 bn to $640.33 bn
- SBI Life Q4 profit rises 4% to ₹811 crore
- IMD predicts severe heatwave conditions over East, South Peninsular India for next five days
- COVID lockdown-related school disruptions will continue to worsen students’ exam results into the 2030s: study
- JNK India IPO allotment date
- JioCinema New Plans
- Realme Narzo 70 Launched
- Apple Let Loose event
- Elon Musk Apology
- RIL cash flows
- Charlie Munger
- Feedbank IPO allotment
- Tata IPO allotment
- Most generous retirement plans
- Broadcom lays off
- Cibil Score vs Cibil Report
- Birla and Bajaj in top Richest
- Nestle Sept 2023 report
- India Equity Market